Article thumbnail
Location of Repository

Psychoactive Medication and Traffic Safety

By Joris C. Verster and Monique A.J. Mets


Driving a car is important to maintain independence and participate in society. Many of those who use psychoactive medication are outpatients and are thus likely to drive a vehicle. Most common adverse effects that impair driving are reduced alertness, affected psychomotor functioning and impaired vision. This review discusses the effects on driving ability of most commonly prescribed psychoactive drugs, including hypnotics, antidepressants, antihistamines, analgesics and stimulant drugs. Within these categories of medicines significant differences concerning their impact on driving ability are evident. The International Council on Alcohol, Drugs and Traffic Safety (ICADTS) categorization can help physicians to make a choice between treatments when patients want to drive a car

Topics: Article
Publisher: Molecular Diversity Preservation International (MDPI)
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1992). A comparative study of on-the-road and simulated driving performance after nocturnal treatment with lormetazepam 1 mg and oxazepam 50 mg.
  2. (2000). A review of the literature on the effects of low doses of alcohol on driving-related skills.
  3. (2006). Acute and subchronic effects of amitriptyline 25 mg on actual driving in chronic neuropathic pain patients.
  4. (2003). Antidepressants and driver impairment: empirical evidence from a standard onthe-road test.
  5. (2004). Antihistamines and driving ability: Evidence from on-the-road driving studies during normal traffic. Annals Allergy, Asthma Immunol.
  6. (1998). Association of road traffic accidents with benzodiazepine use. The Lancet
  7. (1998). Benzodiazepine-related traffic accidents in young and elderly drivers. Human Psychopharm. Clin.
  8. Categorization System for Medicinal Drugs Affecting Driving Performance;
  9. (1982). Diazepam impairs lateral position control in highway driving. Science
  10. (2009). Eds.; Birkhauser Verlag:
  11. (2006). Effects of an opioid (oxycodone / paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size
  12. (2006). Effects of chronic nonmalignant pain on highway driving performance. Pain
  13. (2002). Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females.
  14. (2007). Hypnotics and daytime functioning: effects of sleep medications on cognition, psychomotor skills, and memory functioning in geriatric patients. Current Psychiat. Rev.
  15. (2006). Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test. Current Drug Safety
  16. Is it safe to drive a car when treated with anxiolytics? Evidence from on-the-road driving studies during normal traffic.
  17. Measurement of the effects of psychoactive drugs on driving ability and related psychological processes.
  18. (2008). Methylphenidate and driving ability of adults with attention-deficit hyperactivity disorder: a randomized crossover
  19. (2009). Public Health
  20. (2000). Relationship among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based casecontrol study.
  21. (2004). Residual effects of hypnotics: epidemiology and clinical implications.
  22. (2002). Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor
  23. (2004). Residual effects of sleep medication on driving ability. Sleep Med. Rev.
  24. (1996). Should people taking opioids for medical reasons be allowed to work and drive? Addiction
  25. (2006). Stimulant effects of 3-4-methylendioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal. Addiction
  26. (1986). The relationship between drivers’ blood alcohol concentration (BAC) and actual driving performance during high speed travel. In Alcohol, Drugs and Traffic Safety,
  27. (1992). Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients.
  28. (2004). World report on road traffic injury prevention. World Health Organization:
  29. (2007). Zoplidem and traffic safety – the importance of treatment compliance. Cur. Drug Saf.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.